Meiogenix
Founded 2010 · 20 employees on LinkedIn · 4 known investors
Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops. It serves plant breeders through crop innovation partnerships and large-scale technology licensing, working on both specialty crops (tomato, fruits, vegetables) and field crops (corn, rice, wheat, soybean).
Founders & leadership
RG
Ricardo Garcia de Albain
Investors · 4
Competitors · 3
by search overlap
Logomix4 shared keywordsGenome engineering-based drug discovery and biomanufacturing R&D support.
Phigenix3 shared keywordsPhigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
SEMrush3 shared keywordsSemrush provides competitive intelligence, SEO, keyword research, and content generation tools for growth marketers and small teams to improve visibility and optimize their acquisition funnel across Google and AI search.
Companies competing with Meiogenix for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Meiogenix do?
- Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops. It serves plant breeders through crop innovation partnerships and large-scale technology licensing, working on both specialty crops (tomato, fruits, vegetables) and field crops (corn, rice, wheat, soybean).
- Who are Meiogenix's investors?
- Meiogenix's investors include Genoa Ventures, Kurma Partners, Sofinnova Partners, Casdin Capital.